+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter Double-Blind Study of the Efficacy of Paroxetine versus Clomipramine in Elderly Patients with Major Depression



Multicenter Double-Blind Study of the Efficacy of Paroxetine versus Clomipramine in Elderly Patients with Major Depression



Journal of Aging & PharmacoTherapy 13(2): 7-19




(PDF emailed within 0-6 h: $19.90)

Accession: 063589898

Download citation: RISBibTeXText

DOI: 10.1300/j397v13n02_02


Related references

Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient. L'Encephale 19(3): 257-261, 1993

Paroxetine versus clomipramine in adolescents with severe major depression: A double-blind, randomized, multicenter trial. Journal of the American Academy of Child & Adolescent Psychiatry 42(1): 22-29, 2003

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry 42(1): 22-29, 2002

A multi-centre, double-blind study to compare the efficacy and tolerability of paroxetine and clomipramine in elderly patients with reactive depression. Encephale 19(3): 257-261, 1993

Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression. Journal of Affective Disorders 76(1-3): 191-200, 2003

A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Journal of Clinical Psychiatry 58(3): 112-118, 1997

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatrica Scandinavica. Supplementum 350: 132-134, 1989

Multicenter double-blind randomized parallel-group clinical trial of effectiveness of the combination clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar major depression. European Neuropsychopharmacology 10(Supplement 3): S249, 2000

Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study. International Clinical Psychopharmacology 17(1): 27-32, 2002

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. Journal of Clinical Psychiatry 67(2): 288-296, 2006

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin. Acta Psychiatrica Scandinavica 77(6): 683-688, 1988

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. Journal of Clinical Psychiatry 53 Suppl: 57-60, 1992

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients. Acta Psychiatrica Scandinavica. Supplementum 350: 130-131, 1989

Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. International Journal of Psychiatry in Clinical Practice 6(1): 23-29, 2002

A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. International Clinical Psychopharmacology 15(5): 263-271, 2000